BLLN

BillionToOne, Inc.

• TipRanks·4h ago

  CMS 2027 CLFS proposal skews towards ‘worst end’ for Quest, says Jefferies

• NASDAQ·1d ago

  BillionToOne SVP Sells 1,416 Shares

• NASDAQ·09/03 00:49

  Canaccord Genuity Initiates Coverage of BillionToOne (BLLN) with Buy Rating

• Dow Jones·09/02 15:52

  BillionToOne Initiated at Buy by Canaccord Genuity

• Dow Jones·09/02 15:52

  BillionToOne Price Target Announced at $120.00/Share by Canaccord Genuity

• TipRanks·09/02 10:40

  BillionToOne initiated with a Buy at Canaccord

• TipRanks·09/01 13:25

  BillionToOne announces the launch of Northstar Origin

• TipRanks·09/01 13:15

  BillionToOne launches Northstar Origin, a new liquid biopsy test

• TipRanks·08/18 16:15

  BillionToOne announces publication of study on cfDNA fetal risk assessment

• PR Newswire·08/18 16:08

  Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions

• TipRanks·08/12 00:24

  BillionToOne, Inc. Class A Signals Robust Growth

• Seeking Alpha·08/07 18:41

  BillionToOne: A Softer Quarter After Heightened Expectations

• Dow Jones·08/06 21:01

  BillionToOne Price Target Cut to $130.00/Share From $145.00 by JP Morgan

• Dow Jones·08/06 21:01

  BillionToOne Is Maintained at Overweight by JP Morgan

• Seeking Alpha·08/06 18:23

  BillionToOne sinks as outlook unchanged despite surging revenue